UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

Kalra, PR; Moon, JCC; Coats, AJS; (2002) Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? INTERNATIONAL JOURNAL OF CARDIOLOGY , 85 (2-3) pp. 195-197. 10.1016/S0167-5273(02)00182-1.

Full text not available from this repository.
Type: Article
Title: Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
DOI: 10.1016/S0167-5273(02)00182-1
Keywords: Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, ENABLE study, non-selective endothelin antagonism, Bosentan
UCL classification: UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
URI: http://discovery.ucl.ac.uk/id/eprint/114762
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item